1. Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent;Abe;Eur. J. Pharmacol.,1991
2. Beneficial effects of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan;Abe;J. Pharmacol. Exp. Ther.,1992
3. Effect of MCI-154, a cardiotonic agent, on regional contractile function and myocardial oxygen consumption in the presence and absence of coronary artery stenosis in dogs;Abe;J. Pharmacol. Exp. Ther.,1993
4. Calcium sensitization in perfused beating guinea pig heart by a positive inotropic agent MCI-154;Abe;J. Pharmacol. Exp. Ther.,1996
5. Inotropic and chonotropic profile of MCI-154: comparisoprenalinen with isoprenalineprenaline and imazodan in guinea pig cardiac preparations;Allert;J. Cardiovasc. Pharmacol.,1990